# Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures

> **NCT00152451** · PHASE2 · COMPLETED · sponsor: **UCB S.A. - Pharma Sector** · enrollment: 31 (actual)

## Conditions studied

- Epilepsy, Partial

## Interventions

- **DRUG:** Seletracetam (ucb 44212)

## Key facts

- **NCT ID:** NCT00152451
- **Lead sponsor:** UCB S.A. - Pharma Sector
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2005-05-19
- **Primary completion:** 2006-05-03
- **Final completion:** 2006-05-03
- **Target enrollment:** 31 (ACTUAL)
- **Last updated:** 2024-03-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00152451

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00152451, "Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset Seizures". Retrieved via AI Analytics 2026-09-04 from https://api.ai-analytics.org/clinical/NCT00152451. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*